Topical Herpes Simplex Virus 2 (HSV-2) Vaccination with Human Papillomavirus Vectors Expressing gB/gD Ectodomains Induces Genital-Tissue-Resident Memory CD8(+) T Cells and Reduces Genital Disease and Viral Shedding after HSV-2 Challenge

Liknande verk

• A Herpes Simplex Virus 2 (HSV-2) gD Mutant Impaired for Neural Tropism Is Superior to an HSV-2 gD Subunit Vaccine To Protect Animals from Challenge with HSV-2
  av: Wang, Kening, et al.
  Publicerad: (2015)
• Liposomal gD Ectodomain (gD(1-306)) Vaccine Protects Against HSV2 Genital or Rectal Infection of Female and Male Mice
  av: Olson, K., et al.
  Publicerad: (2009)
• Immunization with a Vaccine Combining Herpes Simplex Virus 2 (HSV-2) Glycoprotein C (gC) and gD Subunits Improves the Protection of Dorsal Root Ganglia in Mice and Reduces the Frequency of Recurrent Vaginal Shedding of HSV-2 DNA in Guinea Pigs Compared to Immunization with gD Alone
  av: Awasthi, Sita, et al.
  Publicerad: (2011)
• Genital Shedding of Herpes Simplex Virus Among Symptomatic and Asymptomatic Persons with HSV-2 Infection
  av: Tronstein, Elizabeth, et al.
  Publicerad: (2011)
• Screening to detect asymptomatic shedding of herpes simplex virus (HSV) in women with recurrent genital HSV infection.
  av: Barton, S E, et al.
  Publicerad: (1986)